Your new post is loading...
One result of the side effects of cancer treatments is that patients often can’t tolerate or survive a combination of different drugs at the same time — which can limit a doctor’s ability to knock out the disease.
The head of a Boston-area biotech called Cerulean Therapeutics thinks the solution is nanoparticle-delivered drugs, which have fewer and less severe side effects. They could make it easier for doctors to mount a multipronged attack on tumors and kill the cells before they can develop a resistance to any one compound.
